EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epitranscriptomic m 6 A modifications during reactivation of HIV-1 latency in CD4 + T cells

Tarun Mishra, Stacia Phillips, Yutao Zhao, Bethany Wilms, Chuan He, Li Wu iD

mBio · 2024

DOI: 10.1128/mbio.02214-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Tarun Mishra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: HIV-1, Virus Latency, CD4-Positive T-Lymphocytes, Virus Activation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute (HHMI), NHGRI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite effective antiretroviral therapy reducing HIV-1 viral loads to undetectable levels, the presence of latently infected CD4 + T cells poses a major barrier to HIV-1 cure. N 6 -methyladenosine (m 6 A) modification of viral and cellular RNA has a functional role in regulating HIV-1 infection. m 6 A modification of HIV-1 RNA can affect its stability, translation, and splicing in cells and suppresses type-I interferon induction in macrophages. However, the function of m 6 A modification in regulating HIV-1 latency reactivation remains unknown. We used the Jurkat T cell line-derived HIV-1 latency model (J-Lat cells) to investigate changes in m 6 A levels of cellular RNA in response to latency reversal. We observed a significant increase in m 6 A levels of total cellular RNA upon reactivation of latent HIV-1 in J-Lat cells. This increase in m 6 A levels was transient and returned to steady-state levels despite continued high levels of viral gene expression in reactivated cells compared to control cells. Upregulation of m 6 A levels occurred without significant changes in the protein expression of m 6 A writers or erasers that add or remove m 6 A, respectively. Knockdown of m 6 A writers in J-Lat cells significantly reduced HIV-1 reactivation. Treatment with an m 6 A writer inhibitor reduced cellular RNA m 6 A levels, along with a reduction in HIV-1 reactivation. Furthermore, using m 6 A-specific sequencing, we identified cellular RNAs that are differentially m 6 A-modified during HIV-1 reactivation in J-Lat cells. Knockdown of identified m 6 A-modified RNA validates these results with an established primary CD4 + T cell model of HIV-1 latency. These results show the importance of m 6 A RNA modification in HIV-1 latency reversal. IMPORTANCE RNA m 6 A modification is important for regulating gene expression and innate immune responses to HIV-1 infection. However, the functional significance of m 6 A modification during HIV-1 latency reactivation is unknown. To address this important question, in this study, we used established cellular models of HIV-1 latency, m 6 A-specific sequencing at single-base resolution, and functional assays. We demonstrate that HIV-1 latency reversal leads to increased levels of cellular m 6 A modification, correlates with cellular m 6 A levels, and is dependent on the catalytic activity of the m 6 A methyltransferase enzyme. We also identified cellular genes that are differentially m 6 A-modified during HIV-1 reactivation, as well as the sites of m 6 A within HIV-1 RNA. Our novel findings point toward a significant role for m 6 A modification in HIV-1 latency reversal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Virus LatencyCD4-Positive T-LymphocytesVirus ActivationAdenosineHIV InfectionsHumansJurkat CellsRNA, ViralEpigenesis, GeneticTranscriptomeGene Expression Regulation, Viral

Stichwörter der Autor:innen

HIV-1 latency reversalJ-Lat cellsPOLR3HRNA m6A modificationTUG1primary CD4+T cells

Substanzen

AdenosineN-methyladenosineRNA, Viral

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
  • Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, Illinois, USA.
  • Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Li Wu

Förderung

  • Howard Hughes Medical Institute (HHMI)
  • NHGRI NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • HHS | National Institutes of Health (NIH)
  • NIAID NIH HHS

Zitieren

APA

Mishra, T., Phillips, S., Zhao, Y., Wilms, B., He, C., & Wu, L. (2024). Epitranscriptomic m 6 A modifications during reactivation of HIV-1 latency in CD4 + T cells. mBio. https://doi.org/10.1128/mbio.02214-24

Vancouver

Mishra T, Phillips S, Zhao Y, Wilms B, He C, Wu L. Epitranscriptomic m 6 A modifications during reactivation of HIV-1 latency in CD4 + T cells. mBio. 2024. doi:10.1128/mbio.02214-24

BibTeX
@article{Mishra2024,
  author = {Mishra, Tarun and Phillips, Stacia and Zhao, Yutao and Wilms, Bethany and He, Chuan and Wu, Li},
  title = {Epitranscriptomic m 6 A modifications during reactivation of HIV-1 latency in CD4 + T cells},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.02214-24}
}
Kostenlos starten →